Results of a phase II study of 506U78 (Nelarabine) in refractory indolent B-cell or peripheral T-cell lymphoma

被引：0
|
作者：
Thompson, MA
Pro, B
Sarris, A
Hagemeister, FB
Goy, A
Bleyer, A
Cabanillas, FF
Samaniego, F
Fayad, LE
机构：
[1] MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA
[2] Hygeia Hosp, Athens, Greece
[3] Harvard Med Int, Athens, Greece
[4] Hackensack Univ, Med Ctr, Div Lymphoma, Ctr Canc, Hackensack, NJ USA
[5] Auxilio Mutuo Hosp, Ctr Canc, San Juan, PR 00919 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2681
引用
收藏
页码：753A / 753A
页数：1
相关论文
共 50 条
  • [21] Ibrutinib in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma: Final Results from a Prospective Phase II Study
    Graf, Solomon A.
    Cassaday, Ryan D.
    Morris, Karolyn K.
    Behnia, Sanaz
    Wu, Qian Vicky
    Voutsinas, Jenna M.
    Lynch, Ryan C.
    Krakow, Elizabeth
    Rasmussen, Heather A.
    Chauncey, Thomas R.
    Kanan, Sandra
    Soma, Lorinda A.
    Smith, Stephen D.
    Gopal, Ajay K.
    BLOOD, 2019, 134
  • [22] Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study
    Kim, Won-Seog
    Fukuhara, Noriko
    Yoon, Dok-Hyun
    Yamamoto, Kazuhito
    Uchida, Toshiki
    Negoro, Eiju
    Izutsu, Koji
    Terui, Yasuhito
    Nakajima, Hideaki
    Ando, Kiyoshi
    Suehiro, Youko
    Kang, Hye Jin
    Ko, Po-Shen
    Nagahama, Fumiko
    Sonehara, Yusuke
    Nagai, Hirokazu
    Tien, Hwei-Fang
    Kwong, Yok-Lam
    Tobinai, Kensei
    BLOOD ADVANCES, 2023, 7 (17) : 4903 - 4912
  • [23] Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T-cell lymphoma
    Maruyama, Dai
    Nagai, Hirokazu
    Maeda, Yoshinobu
    Nakane, Takahiko
    Shimoyama, Tatsu
    Nakazato, Tomonori
    Sakai, Rika
    Ishikawa, Takayuki
    Izutsu, Koji
    Ueda, Ryuzo
    Tobinai, Kensei
    CANCER SCIENCE, 2017, 108 (10): : 2061 - 2068
  • [24] PROPEL: Results of the pivotal, multicenter, phase II study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)
    O'Connor, O.
    Pro, B.
    Pinter-Brown, L.
    Popplewell, L.
    Bartlett, N.
    Lechowicz, M.
    Savage, K.
    Coiffier, B.
    Saunders, M.
    Horwitz, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Belinostat (PXD101) in patients with recurrent or refractory peripheral or cutaneous T-Cell lymphoma: Results of a phase II study
    Advani, Ranjana
    Hymes, K.
    Pohlman, B.
    Jacobsen, E.
    McDonnell, J.
    Belt, R.
    Lerner, A.
    Kim, Y.
    Mundis, R.
    Mansfield, T.
    Buhl-Jensen, P.
    Ooi, C. E.
    Duvic, M.
    Foss, F.
    BLOOD, 2007, 110 (11) : 1012A - 1012A
  • [26] PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE II STUDY OF TIPIFARNIB IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA
    Witzig, T.
    Sokol, L.
    Jacobsen, E.
    Advani, R.
    Mondejar, R.
    Piris, M.
    Burrows, F.
    Melvin, C.
    Mishra, V.
    Scholz, C.
    Gualberto, A.
    HAEMATOLOGICA, 2017, 102 : 222 - 222
  • [27] Primary cutaneous peripheral T-cell lymphoma, unspecified, with an indolent clinical course: a distinct peripheral T-cell lymphoma?
    Ryan, A.
    Hayes, B.
    Robson, A.
    Sheahan, K.
    Collins, P.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 : 57 - 57
  • [28] Primary cutaneous peripheral T-cell lymphoma, unspecified with an indolent clinical course: a distinct peripheral T-cell lymphoma?
    Ryan, A. J. A.
    Robson, A.
    Hayes, B. D.
    Sheahan, K.
    Collins, P.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (08) : 892 - 896
  • [29] Analysis of Patients with Common Peripheral T-Cell Lymphoma Subtypes From a Phase 2 Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma
    Coiffier, Bertrand
    Pro, Barbara
    Prince, H. Miles
    Foss, Francine M.
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Borchmann, Peter
    Morschhauser, Franck
    Wilhelm, Martin
    Pinter-Brown, Lauren
    Padmanabhan, Swaminathan
    Shustov, Andrei R.
    Nichols, Jean
    Carroll, Susan
    Balser, John
    Horwitz, Steven M.
    BLOOD, 2011, 118 (21) : 272 - 272
  • [30] T-CELL RICH B-CELL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY
    BADDOURA, FK
    CHAN, WC
    LABORATORY INVESTIGATION, 1991, 64 (01) : A68 - A68
12345